financetom
Business
financetom
/
Business
/
Cingulate Says Lincoln Park Capital Fund to Offer 1 Million Shares; Increases At-The-Market Offering Limit to $11.3 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cingulate Says Lincoln Park Capital Fund to Offer 1 Million Shares; Increases At-The-Market Offering Limit to $11.3 Million
Aug 19, 2024 5:20 AM

07:50 AM EDT, 08/19/2024 (MT Newswires) -- Cingulate ( CING ) said on Monday that Lincoln Park Capital Fund is offering up to 1 million of its shares.

The company said the shares may be issued and sold to Lincoln Park under a Purchase Agreement dated April 24, 2023.

Cingulate ( CING ) would not receive proceeds from the resale; however, it could receive up to $10.5 million from future sales of purchase shares to Lincoln Park.

Separately, the company has increased the maximum offering price under its at the market offering agreement with H.C. Wainwright to $11.3 million from $8.5 million.

Price: 15.88, Change: -1.81, Percent Change: -10.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Arcos Dorados Shares Are Plunging Today
Why Arcos Dorados Shares Are Plunging Today
Mar 13, 2024
Arcos Dorados Holdings Inc. ( ARCO ) shares are trading lower on Wednesday. The company reported fourth earnings per share of 26 cents, which missed the street view of 31 cents.  Quarterly sales of 1.176 billion outpaced the analyst consensus of $1.150 billion. Sales rose 15.4% year over year. Systemwide comparable sales increased 32.4%, with higher guest traffic and average check driving at...
Why NuCana Stock Is Up Today
Why NuCana Stock Is Up Today
Mar 13, 2024
NuCana Plc ( NCNA ) shares are trading higher Wednesday after the company was granted a U.S. Patent for phosphoramidate derivatives for use in the treatment of cancer. The Details: U.S. Patent #11925658 was granted on Tuesday for “phosphoramidate derivatives for use in the treatment of cancer; especially in the treatment where the patient shows resistance. NuCana ( NCNA )...
Why Is Online Leisure Travel Company Tuniu Stock Rising Today?
Why Is Online Leisure Travel Company Tuniu Stock Rising Today?
Mar 13, 2024
Tuniu Corporation ( TOUR ) shares are trading higher on Wednesday. The company reported the fourth quarter of 2023, where net revenues increased by 265.8% year-over-year to $14.1 million. The increase was primarily due to the growth of packaged tours as the travel market recovers. Revenues from package tours in the fourth quarter of 2023 increased by 1377.1% year-over-year to $10.3 million. Gross profit...
NeuroBo Pharmaceuticals to Continue Trial of Liver Disease Treatment Candidate -- Shares Down
NeuroBo Pharmaceuticals to Continue Trial of Liver Disease Treatment Candidate -- Shares Down
Mar 13, 2024
12:34 PM EDT, 03/13/2024 (MT Newswires) -- NeuroBo Pharmaceuticals ( NRBO ) said Wednesday it received the go-ahead to continue its mid-stage clinical trial of DA-1241 without modification, a treatment for metabolic dysfunction-associated steatohepatitis, a liver disease. A safety review committee approved the continuation following a blinded safety review of the first six months of study conduct, the company said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved